Aptamer-Based Smart Targeting and Spatial Trigger-Response Drug-Delivery Systems for Anticancer Therapy.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Pharmacology
• Oncology

Background:

• The field of drug delivery is advancing towards more precise and effective therapeutic strategies.
• Aptamers and stimuli-responsive systems are emerging as key components for targeted drug delivery, especially in cancer therapy.

Purpose of the Study:

• To review cutting-edge advancements in targeted drug delivery systems.
• To focus on the integration of aptamers and stimuli-responsive platforms for enhanced spatial anticancer therapy.
• To explore the synergistic potential of aptamers with nanomaterials and stimuli-responsive systems for precision medicine.

Main Methods:

• Review of aptamer-based drug delivery systems, including conjugation with gold, silica, and carbon materials.
• Exploration of stimuli-responsive drug delivery systems, focusing on tumor microenvironment-responsive nanoparticles.
• Examination of external stimuli-responsive strategies such as ultrasound-mediated, photo-responsive, and magnetic-guided systems.

Main Results:

• Aptamer-conjugated materials demonstrate potential for precise and targeted drug delivery.
• Tumor microenvironment-responsive nanoparticles enable controlled drug release within cancerous tissues.
• External stimuli-responsive systems show promise for synergistic anticancer effects and spatial control.

Conclusions:

• The integration of aptamers and stimuli-responsive systems offers a powerful approach for spatial anticancer therapy.
• These advanced strategies have the potential to revolutionize drug delivery, paving the way for precision medicine in oncology.
• Further research into these integrated systems is crucial for developing next-generation cancer treatments.